Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Authors

Helena J. Teede, Monash University
Chau Thien Tay, Monash University
Joop Laven, National Health and Medical Research Council Schizophrenia Unit
Anuja Dokras, University of Pennsylvania
Lisa J. Moran, National Health and Medical Research Council Schizophrenia Unit
Terhi T. Piltonen, Medical Research Center Oulu
Michael F. Costello, National Health and Medical Research Council Schizophrenia Unit
Jacky Boivin, College of Biomedical and Life Sciences
Leanne M. Redman, Monash University
Jacqueline A. Boyle, National Health and Medical Research Council Schizophrenia Unit
Robert J. Norman, National Health and Medical Research Council Schizophrenia Unit
Aya Mousa, Monash University
Anju E. Joham, Monash University

Document Type

Article

Publication Date

12-1-2023

Recommended Citation

Teede, H., Tay, C., Laven, J., Dokras, A., Moran, L., Piltonen, T., Costello, M., Boivin, J., Redman, L., Boyle, J., Norman, R., Mousa, A., & Joham, A. (2023). Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Retrieved from https://repository.lsu.edu/clinical_research_pubs/325